Open access · OA
via OpenAlex
Amyloid oligomers: formation and toxicity of Aβ oligomers
FEBS Journal · 2010 · ▲ 585 citations
Abstract
Alzheimer's disease (AD) is an age-related, progressive degenerative disorder that is characterized by synapse and neuron loss in the brain and the accumulation of protein-containing deposits (referred to as 'senile plaques') and neurofibrillary tangles. Insoluble amyloid beta-peptide (Abeta) fibrillar aggregates found in extracellular plaques have long been thought to cause the neurodegenerative cascades of AD. However, accumulating evidence suggests that prefibrillar soluble Abeta oligomers induce AD-related synaptic dysfunction. The size of Abeta oligomers is distributed over a wide molecular weight range (from < 10 kDa to > 100 kDa), with structural polymorphism in Abeta oligomers of similar sizes. Recent studies have demonstrated that Abeta can accumulate in living cells, as well as in extracellular spaces. This review summarizes current research on Abeta oligomers, focusing on their structures and toxicity mechanism. We also discuss possible formation mechanisms of intracellular and extracellular Abeta oligomers.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/j.1742-4658.2010.07568.x
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Sakono, M., & Zako, T. (2010). Amyloid oligomers: formation and toxicity of Aβ oligomers. <em>FEBS Journal</em>. https://doi.org/10.1111/j.1742-4658.2010.07568.x
Vancouver
Sakono M, Zako T. Amyloid oligomers: formation and toxicity of Aβ oligomers. FEBS Journal. 2010. doi:10.1111/j.1742-4658.2010.07568.x.
BibTeX
@article{masafumi2010Amyloi,
title = {Amyloid oligomers: formation and toxicity of Aβ oligomers},
author = {Masafumi Sakono and Tamotsu Zako},
journal = {FEBS Journal},
year = {2010},
doi = {10.1111/j.1742-4658.2010.07568.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brain Structure and Function 2009
Open access · CC-BY
APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
Molecular Neurodegeneration 2009
Open access · OA
Alzheimer's disease: synaptic dysfunction and Aβ
Human Molecular Genetics 2010
Open access · OA
Molecular mechanisms of neurodegeneration in Alzheimer's disease
EMBO Molecular Medicine 2016
Open access · OA
The amyloid hypothesis of Alzheimer's disease at 25 years
Frontiers in Synaptic Neuroscience 2026
Open access · CC-BY
Aging and Alzheimer’s: the critical role of mitochondrial dysfunction and synaptic alterations
Molecules and Cells 2017
Open access · CC-BY